Stroke
Conditions
Interventions
iTBS on antagonist muscle group + sham cTBS on spastic muscle:iTBS on antagonist muscle group + sham cTBS on spastic muscle: Enhancing cortical excitability of antagonist muscles to promote active mot
Sham iTBS over antagonist muscles + cTBS over spastic muscles group:Sham iTBS over antagonist muscles + cTBS over spastic muscles group: Inhibiting reflexive hyperexcitability of spastic muscles to re
Combined iTBS and cTBS group:Professional Translation: Combined iTBS and cTBS Group: Bidirectional Regulation—Enhancing Antagonist Muscle Function + Inhibiting Spastic Muscles to Optimize Synergistic
Sponsors
South China Hospital of Shenzhen University
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age: 40–75 years old First-ever unilateral stroke, with a disease duration of 1–6 months Upper limb motor dysfunction (FMA-UE = 1 Ability to understand and cooperate with assessments and treatment
Exclusion criteria
Exclusion criteria: Comorbid severe cognitive impairment (MMSE < 24) History of epilepsy or metallic implants Severe cardiovascular and pulmonary diseases Prior receipt of brain/spinal cord stimulation therapy Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FMA-UE;WMFT;Barthel Index (MBI); | — |
Countries
China
Contacts
Public ContactJianghua Cheng
South China Hospital of Shenzhen University
Outcome results
None listed